Proactive Investors - Run By Investors For Investors

OptiBiotix buoyed by UK launch of SlimBiome Medical

The weight loss product will be available to buy from Opti's website in boxes of 30 single-dose sachets from 29 April
Weight loss
Opti also reported prelaunch sales to Bridge4 Health, a health and well-being centre, for a three-month field trial to support weight loss among its gym members

OptiBiotix Health PLC (LON:OPTI) shares were buoyed on Wednesday after it launched its SlimBiome Medical weight management product in the UK market.

The company, which develops compounds to help tackle obesity, high cholesterol and diabetes, said SlimBiome would be available to buy from its website in boxes of 30 single-dose sachets from 29 April.

READ: OptiBiotix Health gets licence to manufacture weight management product SlimBiome in India

Opti also reported prelaunch sales to Bridge4 Health Ltd, a health and well-being centre based in Leicester, which would conduct a three-month field trial of the product to support weight loss among its gym members.

Fred Narbel, managing director of Opti’s Prebiotics division, said the UK launch would allow the group to “build early revenues at high margin through direct consumer sales”.

The launch follows SlimBiome receiving a CE mark in November last year, which allows it to be freely marketed within the European Economic Area (EEA).

READ: OptiBiotix surges as SlimBiome granted CE mark and medical device status

Since receiving the mark, the company has signed a slew of distribution deals for countries including Italy, Spain, Greece, Cyprus and Bulgaria.

More recently, the group has expanded its international presence, receiving a licence from the Food Standards and Safety Authority India earlier in April to manufacture SlimBiome in the country.

In mid-morning trading, OptiBiotix shares were up 1.7% at 82.9p.

 -- Adds share price --

View full OPTI profile View Profile

OptiBiotix Health PLC Timeline

Related Articles

CBD oil
November 15 2018
The company’s technology creates nano-scale emulsion mixtures that allow fluids to mix that normally don’t mix, such as CBD oil and water
woman touching her skin
May 21 2019
Here we take a closer look at Integumen PLC (LON:SKIN), which has developed and digitised an artificial skin
PT exercises
December 19 2018
The Californian company is a bet on an industry that is in need of transformation

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use